Literature DB >> 31028829

Insulin resistance and hippocampal dysfunction: Disentangling peripheral and brain causes from consequences.

Claudia A Grillo1, Jennifer L Woodruff1, Victoria A Macht1, Lawrence P Reagan2.   

Abstract

In the periphery insulin plays a critical role in the regulation of metabolic homeostasis by stimulating glucose uptake into peripheral organs. In the central nervous system (CNS), insulin plays a critical role in the formation of neural circuits and synaptic connections from the earliest stages of development and facilitates and promotes neuroplasticity in the adult brain. Beyond these physiological roles of insulin, a shared feature between the periphery and CNS is that decreases in insulin receptor activity and signaling (i.e. insulin resistance) contributes to the pathological consequences of type 2 diabetes (T2DM) and obesity. Indeed, clinical and preclinical studies illustrate that CNS insulin resistance elicits neuroplasticity deficits that lead to decreases in cognitive function and increased risk of neuropsychiatric disorders. The goals of this review are to provide an overview of the literature that have identified the neuroplasticity deficits observed in T2DM and obesity, as well as to discuss the potential causes and consequences of insulin resistance in the CNS, with a particular focus on how insulin resistance impacts hippocampal neuroplasticity. Interestingly, studies that have examined the effects of hippocampal-specific insulin resistance illustrate that brain insulin resistance may impair neuroplasticity independent of peripheral insulin resistance, thereby supporting the concept that restoration of brain insulin activity is an attractive therapeutic strategy to ameliorate or reverse cognitive decline observed in patients with CNS insulin resistance such as T2DM and Alzheimer's Disease.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's; Cognition; Diabetes; Hypothalamus; Neuroinflammation; Obesity

Mesh:

Year:  2019        PMID: 31028829     DOI: 10.1016/j.expneurol.2019.04.012

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  14 in total

1.  Allicin ameliorates obesity comorbid depressive-like behaviors: involvement of the oxidative stress, mitochondrial function, autophagy, insulin resistance and NOX/Nrf2 imbalance in mice.

Authors:  Wenqi Gao; Wei Wang; Jing Zhang; Pengyi Deng; Jun Hu; Jian Yang; Zhifang Deng
Journal:  Metab Brain Dis       Date:  2019-06-14       Impact factor: 3.584

2.  Metforminium Decavanadate (MetfDeca) Treatment Ameliorates Hippocampal Neurodegeneration and Recognition Memory in a Metabolic Syndrome Model.

Authors:  Alfonso Diaz; Guadalupe Muñoz-Arenas; Berenice Venegas; Rubén Vázquez-Roque; Gonzalo Flores; Jorge Guevara; Enrique Gonzalez-Vergara; Samuel Treviño
Journal:  Neurochem Res       Date:  2021-02-09       Impact factor: 3.996

3.  Plasma Leptin Reflects Progression of Neurofibrillary Pathology in Animal Model of Tauopathy.

Authors:  Martin Cente; Stefan Zorad; Tomas Smolek; Lubica Fialova; Natalia Paulenka Ivanovova; Katarina Krskova; Lucia Balazova; Rostislav Skrabana; Peter Filipcik
Journal:  Cell Mol Neurobiol       Date:  2020-09-30       Impact factor: 5.046

Review 4.  Memory and eating: A bidirectional relationship implicated in obesity.

Authors:  Marise B Parent; Suzanne Higgs; Lucy G Cheke; Scott E Kanoski
Journal:  Neurosci Biobehav Rev       Date:  2021-11-20       Impact factor: 8.989

Review 5.  Peripheral versus central insulin and leptin resistance: Role in metabolic disorders, cognition, and neuropsychiatric diseases.

Authors:  Jennifer M Erichsen; Jim R Fadel; Lawrence P Reagan
Journal:  Neuropharmacology       Date:  2021-11-08       Impact factor: 5.250

Review 6.  Mechanisms affecting brain remodeling in depression: do all roads lead to impaired fibrinolysis?

Authors:  Silvia Hoirisch-Clapauch
Journal:  Mol Psychiatry       Date:  2021-08-17       Impact factor: 15.992

7.  High-fat diet induces neuroinflammation and reduces the serotonergic response to escitalopram in the hippocampus of obese rats.

Authors:  Melinda Hersey; Jennifer L Woodruff; Nicholas Maxwell; Alia T Sadek; Maria K Bykalo; Ian Bain; Claudia A Grillo; Gerardo G Piroli; Parastoo Hashemi; Lawrence P Reagan
Journal:  Brain Behav Immun       Date:  2021-05-16       Impact factor: 19.227

Review 8.  Shared (epi)genomic background connecting neurodegenerative diseases and type 2 diabetes.

Authors:  Valerio Caputo; Andrea Termine; Claudia Strafella; Emiliano Giardina; Raffaella Cascella
Journal:  World J Diabetes       Date:  2020-05-15

9.  The immune-opioid axis in prediabetes: predicting prediabetes with insulin resistance by plasma interleukin-10 and endomorphin-2 to kappa-opioid receptors ratio.

Authors:  Shatha Rouf Moustafa
Journal:  Diabetol Metab Syndr       Date:  2021-06-07       Impact factor: 3.320

Review 10.  Metabolic Syndrome: Is It Time to Add the Central Nervous System?

Authors:  Milagros Rojas; Mervin Chávez-Castillo; Daniela Pirela; Heliana Parra; Manuel Nava; Maricarmen Chacín; Lissé Angarita; Roberto Añez; Juan Salazar; Rina Ortiz; Samuel Durán Agüero; Marbel Gravini-Donado; Valmore Bermúdez; Edgar Díaz-Camargo
Journal:  Nutrients       Date:  2021-06-30       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.